These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31316988)

  • 21. Clinicopathological Significances and Prognostic Role of Intratumoral Budding in Colorectal Cancers.
    Kang G; Pyo JS; Kim NY; Kang DW
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.
    Zlobec I; Lugli A; Baker K; Roth S; Minoo P; Hayashi S; Terracciano L; Jass JR
    J Pathol; 2007 Jul; 212(3):260-8. PubMed ID: 17516584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts.
    Guil-Luna S; Mena R; Navarrete-Sirvent C; López-Sánchez LM; Khouadri K; Toledano-Fonseca M; Mantrana A; Guler I; Villar C; Díaz C; Medina-Fernández FJ; De la Haba-Rodríguez JR; Aranda E; Rodríguez-Ariza A
    Front Med (Lausanne); 2020; 7():264. PubMed ID: 32719800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential prognostic role of peritumoral eosinophils within whole tumor-associated inflammatory cells and stromal histological characteristics in colorectal cancer.
    Ramadan S; Saka B; Yarikkaya E; Bilici A; Oncel M
    Pol J Pathol; 2020; 71(3):207-220. PubMed ID: 33112111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data.
    Trinh A; Lädrach C; Dawson HE; Ten Hoorn S; Kuppen PJK; Reimers MS; Koopman M; Punt CJA; Lugli A; Vermeulen L; Zlobec I
    Br J Cancer; 2018 Nov; 119(10):1244-1251. PubMed ID: 30385823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
    Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
    Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological Significances of Peritumoral Budding in Colorectal Cancer: A Detailed Analysis Based on Mucinous and Micropapillary Pattern.
    Pyo JS; Kim NY; Min KW; Kang DW
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical evaluation of tumor budding in colorectal cancer: an important parameter with prognostic value.
    Meşină C; Stoean CL; Stoean R; Săndiţă AV; Dumitrescu TV; Mogoantă SŞ; Cristian DA; Meşină-Botoran MI; Mitroi G; Gruia CL; Foarfă MC; Meşină M; Ciobanu D
    Rom J Morphol Embryol; 2019; 60(3):841-846. PubMed ID: 31912094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
    Weis CA; Kather JN; Melchers S; Al-Ahmdi H; Pollheimer MJ; Langner C; Gaiser T
    Diagn Pathol; 2018 Aug; 13(1):64. PubMed ID: 30153844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous expression of Lgr5 as a risk factor for focal invasion and distant metastasis of colorectal carcinoma.
    Zheng Z; Yu H; Huang Q; Wu H; Fu Y; Shi J; Wang T; Fan X
    Oncotarget; 2018 Jul; 9(53):30025-30033. PubMed ID: 30046385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-yield areas to grade tumor budding in colorectal cancer: A practical approach for pathologists.
    Aldyab M; Pacheco RR; Najjar S; Rand JV; Lee H
    Ann Diagn Pathol; 2023 Apr; 63():152085. PubMed ID: 36577186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma.
    Konishi Y; Kawamata F; Nishihara H; Homma S; Kato Y; Tsuda M; Kohsaka S; Einama T; Liu C; Yoshida T; Nagatsu A; Tanino M; Tanaka S; Kawamura H; Kamiyama T; Taketomi A
    Med Oncol; 2018 Jun; 35(7):104. PubMed ID: 29892782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.
    Jepsen RK; Klarskov LL; Lippert MF; Novotny GW; Hansen TP; Christensen IJ; Høgdall E; Riis LB
    Pathol Res Pract; 2018 Sep; 214(9):1273-1281. PubMed ID: 30017334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gland Attenuation, a Novel Morphological Feature of Colorectal Cancer: Evidence for an Epithelial-Mesenchymal Transition.
    Baek TH; Kang DW; Kim JH; Son HJ
    Ann Coloproctol; 2018 Aug; 34(4):187-196. PubMed ID: 30208682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High KRT17 expression in tumour budding indicates immunologically 'hot' tumour budding and predicts good survival in patients with colorectal cancer.
    Liang W; Jie H; Xie H; Zhou Y; Li W; Huang L; Liang Z; Liu H; Zheng X; Zeng Z; Kang L
    Clin Transl Immunology; 2024; 13(3):e1495. PubMed ID: 38433762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Relationship between Tumor Budding and Tumor Deposits in Patients with Stage III Colorectal Carcinoma.
    Bilić Z; Zovak M; Glavčić G; Mužina D; Ibukić A; Košec A; Tomas D; Demirović A
    J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.